Program Annual Meeting 2023
Thursday, July 27, 2023
7:00 AM – 8:00 AM
Industry Sponsored Symposium
8:15 AM – 8:30 AM
Opening Remarks, Presidential & Program Chair Welcome
8:30 AM – 9:30 AM
General Session 1
Moderator:
Gweneth B. Lazenby (Medical University of South Carolina)
8:30 AM – 9:15 AM
Clinical and Pathological Features of Septic Abortion
Speaker:
David M. Aronoff, MD, FIDSA, FAAM (Indiana University School of Medicine)
9:15 AM – 9:30 AM
Q&A
Speaker:
David M. Aronoff, MD, FIDSA, FAAM (Indiana University School of Medicine)
9:30 AM – 10:15 AM
Oral Abstract Session 1
Moderators:
Chelsea Elwood (University of British Columbia) & Kristen Warncke (University of Texas Southwestern Medical Center)
9:30 AM – 9:45 AM
Population Pharmacokinetics of Sofosbuvir/Velpatasvir in Pregnant Women with Hepatitis C Virus (#001)
Speaker:
Riley Randolph (University of Colorado Anschutz Medical Campus)
9:45 AM – 10:00 AM
The Effect of HCV on Methadone Dose During Pregnancy (#002)
Speaker:
Sarah Boudova (Thomas Jefferson University)
10:00 AM – 10:15 AM
Hepatitis C Virus Infection Across Multiple Pregnancies, Surveillance for Emerging Threats to Pregnant Persons and Infants Network – 2018-2021 (#003)
Speaker:
Suzanne Newton (Centers for Disease Control and Prevention)
10:15 AM – 10:30 AM
Break
10:30 AM – 11:30 AM
Oral Abstract Session 2
Moderators:
Sarah Boudova (Thomas Jefferson University) & Andrés Ramírez Zamudio (Icahn School of Medicine at Mount Sinai)
10:30 AM – 10:45 AM
Pregnancy Characteristics and Birth Outcomes in People with Mpox Infection During Pregnancy – Surveillance for Emerging Threats to Pregnant People and Infants Network (#004)
Speaker:
Varsha Neelam (Centers for Disease Control and Prevention)
10:45 AM – 11:00 AM
Geographic Distribution and Characteristics of Inadequate Maternal Syphilis Treatment (#005)
Speaker:
Kristen Warncke (University of Texas Southwestern Medical Center)
11:00 AM – 11:15 AM
Universal Prenatal Screening for Chagas Disease in an At-Risk Population (#006)
Speaker:
Barbara Neuhoff (University of Texas Health Science Center at San Antonio (UTHSCSA))
11:15 AM – 11:30 AM
Increased Uptake of Intermittent Preventive Treatment for Prevention of Malaria in Pregnancy and Scale-Up of Group Antenatal Care in Nasarawa State, Nigeria (#007)
Speaker:
Lisa Noguchi (Johns Hopkins Bloomberg School of Public Health)
11:30 AM – 12:15 PM
Stump the Professors
Speaker:
Sarah Boudova (Thomas Jefferson University)
Moderators:
David M. Aronoff, MD, FIDSA, FAAM (Indiana University School of Medicine), Jennifer Balkus, PhD, MPH (University of Washington, Seattle, WA), Catherine Chappell, MD, MSc (Magee-Womens Hospital of UPMC) & Patrick Ramsey, MD, MSPH (University of Texas Health Sciences Center at San Antonio)
12:15 PM – 12:45 PM
Break
12:45 PM – 1:45 PM
Industry Sponsored Symposium
1:45 PM – 2:45 PM
Poster Session 1
Revealing Mechanisms of Female Sexual Dysfunction Through Multi-Omics Analysis of the Vaginal Microenvironment (#022)
Speaker:
Phoebe Crossley (University of Arizona)
Chlamydia Screening Practices and Positivity Rates in University versus Regional Medical Centers (#023)
Speaker:
Nicolina Mascia (Department of Obstetrics and Gynecology, Medical University of South Carolina)
Vaginal and Gastrointestinal Microbiome in Patients with Chronic Pelvic Pain (#024)
Speaker:
Emerald Bell (Basic Medical Sciences, College of Medicine-Phoenix, University of Arizona)
High Social Vulnerability Associated with Lower Likelihood of Chlamydia Screening among Pregnant Women: A Prospective Surveillance Study (#025)
Speaker:
Bethany Bruno (Medical University of South Carolina)
Uterotonic Management of Postpartum Hemorrhage in Pregnancies Affected by Intra-amniotic Infection (#026)
Speaker:
Michaela Y. Lee (UT Health San Antonio)
Outcomes in Adolescent Pregnant Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2 (#027)
Speaker:
Sebastian Nasrallah (Inova Fairfax Hospital)
Impact of COVID-19 on Vaccination Rates Among Pregnant Patients (#028)
Speaker:
Ravyn Njagu (Duke University)
Determinants of Bacteroides Stability in the Neonatal Gut Microbiome (#029)
Speaker:
Ofri Bar (Massachusetts General Hospital)
Association Of Bacterial Vaginosis With Chlamydia Trachomatis Infection Among Women In Mombasa, Kenya: A Nested Case-Control Study (#030)
Speaker:
Omolara Akingba (University of Washington)
HPV Vaccination: Broadening the Scope of Education and Administration (#031)
Speaker:
Jill Maples (University of Tennessee Graduate School of Medicine)
COVID-19 Maternal Antibody Concentrations in Small for Gestational Age Infants: Does Placental Insufficiency Impact Transplacental Antibody Transfer? (#032)
Speaker:
Alisa Kachikis (University of Washington Department of Obstetrics & Gynecology)
Neonatal Survival and Morbidity Following Expectant Management of Previable Premature Rupture of Membranes at a Single Center (#033)
Speaker:
Jennifer Cate (Duke University)
Comparison of Maternal and Infant Outcomes in SARS-COV-2 Affected Pregnancies and Contemporaneous Pregnancies from British Columbia, Canada (#034)
Speaker:
Winnie Fu (University of British Columbia)
Morbidity in Expectant Management of Pre-viable Preterm Prelabor Rupture of Membranes (#035)
Speaker:
Colleen Judge-Golden (Duke University Hospital)
Alinity m HR HPV Investigational Use Only (IUO) Assay: Designed to Meet US Guidelines for Managing Patients in Cervical Cancer Screening Programs (#036)
Speaker:
Josh Kostera (Abbott Laboratories)
Maternal Outcomes of Parvovirus B19 Infections in Pregnancy (#037)
Speaker:
Jennifer Okunbor (Duke University School of Medicine)
Estimating the Burden of Infant Group B Streptococcus Disease in Ontario, Canada: a Population-Based Cohort Study (#038)
Speaker:
Romina Fakhraei (University of Ottawa)
SARS CoV2 Viral Load and Outcomes in Pregnant and Non-pregnant Women Admitted with COVID-19 (#039)
Speaker:
Juliann Wang (University of Alabama at Birmingham, Marnix E. Heersink School of Medicine)
Maternal Cytomegalovirus Reinfection during Pregnancy among Women Living with HIV (#040)
Speaker:
Elisabeth McClymont (University of British Columbia)
Incidence and Symptom Profiling of Vaginitis Containing Aerobic and Anaerobic Pathogens (#041)
Speaker:
Pita Navarro (Evvy)
Characteristics Associated with Hepatitis C Virus Test Timing During Pregnancy among People with Opioid Use Disorder (#042)
Speaker:
Kathryn Miele (Centers for Disease Control and Prevention)
Feasibility of Mechanical Lysis of Fungal Pathogens for a Future Vulvovaginal Candidiasis Test on a Rapid Molecular Point-of-Care System* (#043)
Speaker:
Rena Dvoretzky (Talis Biomedical)
Maternal Perceptions of Tdap Vaccination and Dissonance between Vaccine Status and Perception (#044)
Speaker:
Alissa Paudel (University of Tennessee Graduate School of Medicine)
Gonococcal Endocarditis, a Life-Threatening Complication of a “Screenable” Infection
Speakers:
Denise Ornelas (University of California, Riverside, School of Medicine) & Diana Ornelas (University of California, Riverside, School of Medicine)
Peripartum Infection of the Pubic Symphysis by an Unusual Organism
Speaker:
Mary Fang (Department of Obstetrics and Gynecology, Baylor College of Medicine)
Don’t Trust the Culture: A Surprising Diagnosis for maternal and neonatal illness
Speaker:
Nir Meller (Sheba Medical Center, Israel)
3:00 PM – 5:00 PM
Mt. Harvard Room
CDC Focus Group*
5:00 PM – 6:30 PM
Welcome Reception
Friday, July 28, 2023
7:00 AM – 8:00 AM
Industry Sponsored Symposium
8:15 AM – 9:15 AM
General Session 2
Moderator:
Gweneth B. Lazenby (Medical University of South Carolina)
8:15 AM – 9:00 AM
Breastfeeding in people with HIV: Where have we been and where are we going?
Speaker:
Lisa Rahangdale, MD, MPH (UNC School of Medicine)
9:00 AM – 9:15 AM
Q&A
Speaker:
Lisa Rahangdale, MD, MPH (UNC School of Medicine)
9:15 AM – 10:15 AM
Oral Abstract Session 3
Moderators:
Gweneth B. Lazenby (Medical University of South Carolina) & Anna Powell (Johns Hopkins School of Medicine)
9:15 AM – 9:30 AM
Determining the Pharmacokinetics of Azithromycin in Pregnant Subjects Undergoing Cesarean Delivery After Failed Labor (#008)
Speaker:
Miriam Estin (Duke University Hospital)
9:30 AM – 9:45 AM
Secreted Proteases from Vaginal Prevotella Species Target and Mimic Human MMPs and Modulate Endocervical Barrier Function (#009)
Speaker:
Karen Lithgow (University of Calgary)
9:45 AM – 10:00 AM
Impact of Chlorhexidine and Povidone-Iodine Antiseptic Solutions on the Vaginal Microbiome in Women Undergoing Gynecologic Surgeries: a Pilot Study (#010)
Speaker:
Pawel Laniewski (University of Arizona)
10:00 AM – 10:15 AM
Gardnerella Species Variations Show Pathogenic and Metabolic Differences (#011)
Speaker:
Pita Navarro (Evvy)
10:15 AM – 10:30 AM
Break
10:30 AM – 11:15 AM
Oral Abstract Session 4
Moderators:
Amanda Adams (Harvard School of Public Health) & Alisa Kachikis (University of Washington Department of Obstetrics & Gynecology)
10:30 AM – 10:45 AM
Vaginal Microbiota Linked to HIV Acquisition Risk Are Not Associated with Changes in Concentrations of Cervical Dendritic Cells and CD4+ T Cells (#012)
Speaker:
Michelle C. Sabo (University of Washington)
10:45 AM – 11:00 AM
Bacterial Cell Wall Reduces Herpesvirus Infection (#013)
Speaker:
Amanda Adams (Harvard School of Public Health)
11:00 AM – 11:15 AM
HIV Vertical Transmission and Adverse Pregnancy Outcomes among People Living with and without HIV with and without Syphilis-Co-infection in Southern Brazil, 2008-2018 (#014)
Speaker:
Lanbo Yang (Warren Alpert Medical School of Brown University)
11:15 AM – 12:15 PM
President’s Forum
Speakers:
Richard Beigi, MD, MSc, Dana Meaney-Delman, MD, MPH, FACOG, Amy Murtha, MD & Laura Riley, MD
Moderator:
Geeta Swamy, MD
12:15 PM – 12:45 PM
Break
12:45 PM – 1:45 PM
Industry Sponsored Symposium
1:45 PM – 2:45 PM
Poster Session 2
Preferences for Pediatric and Perinatal HCV Screening and Treatment from Focus Group with Sex Workers. (#045)
Speaker:
Caleb Smith (Drexel University)
Characterizing the Preferences of Pregnant People for Preventives to Protect Their Infants Against Respiratory Syncytial Virus (#046)
Speaker:
Amy Law (Pfizer, Inc.)
Barriers to Infection Prevention and Control Practices in the Labor and Delivery Setting (#047)
Speaker:
Marisa R. Young (Department of Gynecology and Obstetrics, Emory University School of Medicine)
Human Immunodeficiency Virus Diagnosis During Pregnancy and Missed Opportunities for Pre-conception Diagnosis (#048)
Speaker:
Alyssa Kretz (Johns Hopkins School of Medicine)
Bacterial Vaginosis, Vaginal PH, and Sexually Transmitted Infections: Neisseria Gonorrhoeae, Chlamydia Trachomatis, Trichomonas Vaginalis (#049)
Speaker:
Stephanie McLaughlin (University of Washington)
Differences in Indications for Delivery Based on COVID-19 Infections Status Among an Underserved Pregnant Cohort: A Prospective Cohort Study (#050)
Speaker:
Mary Fang (Department of Obstetrics and Gynecology, Baylor College of Medicine)
Vaginitis Polymerase Chain Reaction (PCR) Testing and Occurrence of Mixed Infections: Results from a Large US Clinical Laboratory (#051)
Speaker:
Andrew Gunter (Quest Diagnostics)
Postpartum Antibiotic and Probiotic Use and Infant Feeding Patterns in a Low-risk, Term Birth Cohort from British Columbia, Canada (#052)
Speaker:
Elisabeth McClymont (University of British Columbia)
HIV Tests and Diagnoses During Pregnancy Among People with Opioid Use Disorder (#053)
Speaker:
Savannah Hammerton (University of Georgia)
Syphilis Screening During Pregnancy Among People with Opioid Use Disorder (#054)
Speaker:
Kathryn Miele (Centers for Disease Control and Prevention)
Comparisons of Perceptions About Novel Respiratory Virus Vaccines Among Pregnant and Non-Pregnant Healthcare Workers (#055)
Speaker:
Candace Haghighi (Wake Forest School of Medicine)
Practice, Policy and Evidence Facilitating Promotion of Vaccination in Pregnancy in Canada: a Scoping Review (#056)
Speaker:
Monica Surti (University of Calgary)
Breast Milk Feeding Initiation among Pregnant Persons with Hepatitis C Virus Infection – Surveillance for Emerging Threats to Pregnant People and Infants Network (#057)
Speaker:
Daniel Chang (Eagle Global Scientific)
Perception of a Group B Streptococcus Vaccine (GBS) Among Pregnant and Lactating Individuals following the COVID-19 Vaccine Experience (#058)
Speaker:
Monica Sosa (Department of Obstetrics and Gynecology, University of Washington, Seattle.)
Erythropoietin Levels in Pregnant Patients with Anemia and Pyelonephritis (#059)
Speaker:
Noor Al-Shibli (Duke University, Department of Obstetrics and Gynecology)
Feasibility of a 30-Minute Sample-to-Answer Chlamydia Trachomatis, Neisseria Gonorrhea, and Trichomonas Vaginalis Multiplex Test on a Rapid Molecular Point-of-Care System* (#060)
Speaker:
Brittney Nguyen (Talis Biomedical)
Is Gravidity Associated with COVID-19 Vaccination among Pregnant Women in Jamaica? (#061)
Speaker:
Jodian Pinkney (Massachusetts General Hospital)
Provider Knowledge and Use of Processes Associated with Increasing HPV Vaccination (#062)
Speaker:
Jill Maples (University of Tennessee Graduate School of Medicine)
Antepartum Risk Factors for Neonatal Necrotizing Enterocolitis and Bowel Perforations (#063)
Speaker:
Walker Phillips (Frederick P. Whiddon College of Medicine)
Incident Bacterial Vaginosis in a Community-Based Cohort of Women (#064)
Speaker:
Christina Muzny (University of Alabama at Birmingham, Division of Infectious Diseases)
Clinical Utility and Evaluation of the Alinity m STI assay at a Large Academic Medical Center in the Southeastern United States (#066)
Speaker:
Josh Kostera (Abbott Laboratories)
COVID-19 Vaccine Hesitancy During Pregnancy: A Qualitative Study (#067)
Speaker:
Imaima Casubhoy (Johns Hopkins Bloomberg School of Public Health)
3:00 PM – 5:00 PM
Mt. Harvard Room
CDC Focus Group*
7:00 PM – 11:00 PM
Awards Ceremony/Dinner Dance
Saturday, July 29, 2023
8:00 AM – 8:45 AM
Annual Business Meeting
8:45 AM – 9:45 AM
General Session 3
Moderator:
Gweneth B. Lazenby (Medical University of South Carolina)
8:45 AM – 9:30 AM
Anal Cancer Screening: What the OBGYN Needs to Know
Speaker:
Christine Conageski, MD, MSc (University of Colorado SOM)
9:30 AM – 9:45 AM
Q&A
9:45 AM – 10:45 AM
Oral Abstract Session 5
Moderators:
Gweneth B. Lazenby (Medical University of South Carolina) & Kendall Moore (Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA)
9:45 AM – 10:00 AM
Changes in Vaginal Bacteria and Inflammatory Mediators from Periconception through Early-Postpartum in a Cohort of HIV-negative Kenyan Women (#019)
Speaker:
Michelle C. Sabo (University of Washington)
10:00 AM – 10:15 AM
Analysis of Dried Blood Spot and Saliva PCR Screening for Detection of Congenital Cytomegalovirus Infection Informs Implementation of a Novel Universal Newborn Screening Program (#016)
Speaker:
Daniel Landers (University of Minnesota Medical School and M Health Fairview Health System)
10:15 AM – 10:30 AM
Association Between Glycemic Control and Group B Streptococcus Colonization Among Pregnant Individuals with Pregestational Diabetes (#017)
Speaker:
Tracy Caroline Bank (Ohio State University Wexner Medical Center)
10:30 AM – 10:45 AM
Neighborhood Socioeconomic Disadvantage and Group B Streptococcus Colonization in Pregnancy (#018)
Speaker:
Tracy Caroline Bank (Ohio State University Wexner Medical Center)
10:45 AM – 11:00 AM
Break
11:00 AM – 11:45 AM
Oral Abstract Session 6
Moderators:
Gweneth B. Lazenby (Medical University of South Carolina) & Lisa Noguchi (Johns Hopkins Bloomberg School of Public Health)
11:00 AM – 11:15 AM
Effectiveness of Maternal Influenza Vaccination During Pregnancy Against Influenza-Associated Emergency Department Visits and Hospitalizations in Infants <6 Months of Age (#015)
Speaker:
Samantha Olson (CDC)
11:15 AM – 11:30 AM
Prospective Cohort Study Examining the Association between Vaginal Washing and Neisseria gonorrhoeae Infection in Women Who Engage in Sex Work in Mombasa, Kenya (#020)
Speaker:
Stephanie McLaughlin (University of Washington)
11:30 AM – 11:45 AM
SARS-CoV-2 Infection During Pregnancy and Gene Co-expression Network Analyses of the Placental Transcriptome (#021)
Speaker:
Kendall Moore (Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA)
11:45 AM – 12:00 PM
Wrap Up/Adjourn Meeting